As of Feb 20, 2025, Chemed Corporation Intrinsic Value is $384.9. This suggests it may be overvalued by 30.1% compared to its current price of around $550.6.
As of Feb 20, 2025, Chemed Corporation's Discounted Cash Flow (DCF) valuation estimates its share price at $466.8. This suggests it may be overvalued by 15.2% to its current price of around $550.6, using a discount rate of 7.6% and terminal growth rate of 3.0%.
Chemed Corporation is currently considered overvalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $384.9, compared to a market price of around $550.6. This suggests a potential overvaluation of 30.1%.